PL1817065T3 - Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę - Google Patents

Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę

Info

Publication number: PL1817065T3
Authority: PL; Poland
Prior art keywords: sodium hyaluronate; preparation; hydroxypropylmethyl; cellulose; solutions containing
Prior art date: 2004-11-30

Application number

PL05818937T

Other languages

English (en)

Inventor

Pierre Lebreton

Original Assignee

Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-30

Filing date

2005-11-28

Publication date

2011-09-30

2005-11-28 Application filed by Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna filed Critical Valeant Spolka Z Ograniczona Odpowiedzialnoscia Spolka Jawna

2011-09-30 Publication of PL1817065T3 publication Critical patent/PL1817065T3/pl

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 title abstract 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 title abstract 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 title abstract 3
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 title abstract 3
229940010747 sodium hyaluronate Drugs 0.000 title abstract 3
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 3
239000008154 viscoelastic solution Substances 0.000 title 1
239000007943 implant Substances 0.000 abstract 2
239000007864 aqueous solution Substances 0.000 abstract 1
230000036571 hydration Effects 0.000 abstract 1
238000006703 hydration reaction Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000001356 surgical procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Surgery (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)

PL05818937T 2004-11-30 2005-11-28 Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę PL1817065T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0412662A FR2878444B1 (fr)	2004-11-30	2004-11-30	Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
PCT/FR2005/050996 WO2006059029A2 (fr)	2004-11-30	2005-11-28	Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethyl- cellulose, preparation et utilisations
EP05818937A EP1817065B1 (fr)	2004-11-30	2005-11-28	Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethylcellulose

Publications (1)

Publication Number	Publication Date
PL1817065T3 true PL1817065T3 (pl)	2011-09-30

Family

ID=34952867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05818937T PL1817065T3 (pl)	2004-11-30	2005-11-28	Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę

Country Status (11)

Country	Link
US (1)	US20080089918A1 (pl)
EP (1)	EP1817065B1 (pl)
JP (1)	JP2008521464A (pl)
AT (1)	ATE499121T1 (pl)
CA (1)	CA2589397C (pl)
DE (1)	DE602005026555D1 (pl)
DK (1)	DK1817065T3 (pl)
ES (1)	ES2364355T3 (pl)
FR (1)	FR2878444B1 (pl)
PL (1)	PL1817065T3 (pl)
WO (1)	WO2006059029A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
WO2008147867A2 (en) *	2007-05-23	2008-12-04	Allergan, Inc.	Cross-linked collagen and uses thereof
US20120071437A1 (en)	2007-07-30	2012-03-22	Allergan, Inc.	Tunable crosslinked polysaccharide compositions
US8318695B2 (en) *	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US8697044B2 (en)	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en)	2007-11-16	2012-02-14	Allergan, Inc.	Compositions and methods for treating purpura
US8394784B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en)	2008-09-02	2014-12-11	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110171286A1 (en) *	2010-01-13	2011-07-14	Allergan, Inc.	Hyaluronic acid compositions for dermatological use
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Stable hydrogel compositions including additives
US20110171310A1 (en)	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
CN102905677A (zh)	2010-03-12	2013-01-30	阿勒根工业有限公司	用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物
ES2585388T5 (es)	2010-03-22	2019-08-08	Allergan Inc	Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
CA2824483C (en)	2011-01-13	2016-08-30	Allergan, Inc.	Stable hydrogels comprising cross-linked hyaluronic acid and phenylephrine
AU2012217630A1 (en)	2011-02-17	2013-09-05	Allergan, Inc.	Compositions and improved soft tissue replacement methods
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
KR102312056B1 (ko)	2011-06-03	2021-10-12	알러간 인더스트리 에스에이에스	항산화제를 포함하는 피부 충전제 조성물
EP3590495A1 (en)	2011-08-25	2020-01-08	Allergan, Inc.	Dermal filler compositions including antioxidants
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
AU2012308503B2 (en)	2011-09-14	2015-08-13	Allergan Industrie, Sas	Dermal filler compositions for fine line treatment
GB201118586D0 (en) *	2011-10-27	2011-12-07	Turzi Antoine	New A-PRP medical device, manufacturing machine and process
PL3175840T3 (pl)	2011-12-08	2021-01-25	Allergan Industrie, Sas	Kompozycje wypełniacza skórnego
KR102062420B1 (ko)	2012-07-18	2020-01-03	알러간 인더스트리 에스에이에스	피루베이트를 함유한 히알루론산 제제
CA2886115A1 (en)	2012-10-02	2014-04-10	Allergan, Inc.	Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes
WO2014055895A1 (en)	2012-10-05	2014-04-10	Allergan, Inc.	Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
CN105142678A (zh) *	2012-11-02	2015-12-09	赛萨卡股份有限公司	用于眼部手术的荧光着色
EP2928426A2 (en)	2012-12-07	2015-10-14	Cesacar Participacions, S.L.	Femto second multi shooting for eye surgery
JP2017509433A (ja)	2014-04-01	2017-04-06	クロックステクノロジーズインコーポレイテッドＫｌｏｘＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	組織充填剤組成物および使用方法
WO2016051219A1 (en)	2014-09-30	2016-04-07	Allergan Industrie, Sas	Stable hydrogel compositions including additives
KR20170108986A (ko)	2015-01-28	2017-09-27	알레간 인코포레이티드	관절 지방 패드 제제 및 그의 사용 방법
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
PL3256179T3 (pl)	2015-02-13	2020-05-18	Allergan Industrie, Sas	Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
AU2016426150B2 (en)	2016-10-13	2022-06-30	Allergan, Inc.	Coacervate hyaluronan hydrogels for dermal filler applications
CA3127191A1 (en)	2019-01-21	2020-07-30	Eclipse Medcorp, Llc	Methods, systems and apparatus for separating components of a biological sample
MX2022004999A (es)	2019-10-31	2022-07-27	Eclipse Medcorp Llc	Sistemas, metodos y aparatos para separar componentes de una muestra.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409904A (en) *	1984-11-13	1995-04-25	Alcon Laboratories, Inc.	Hyaluronic acid compositions and methods
JPS62122671A (ja) *	1985-11-23	1987-06-03	千寿製薬株式会社	眼内手術用高粘性液の製造法
WO1995007085A1 (en) *	1993-09-07	1995-03-16	Escalon Ophthalmics, Inc.	Surface active viscoelastic solutions for ocular use
AU2002360752A1 (en) *	2001-12-21	2003-07-30	Alcon, Inc.	Viscoelastics for ocular surgery

2004
- 2004-11-30 FR FR0412662A patent/FR2878444B1/fr not_active Expired - Fee Related
2005
- 2005-11-28 AT AT05818937T patent/ATE499121T1/de active
- 2005-11-28 EP EP05818937A patent/EP1817065B1/fr not_active Expired - Lifetime
- 2005-11-28 CA CA2589397A patent/CA2589397C/en not_active Expired - Lifetime
- 2005-11-28 US US11/791,603 patent/US20080089918A1/en not_active Abandoned
- 2005-11-28 WO PCT/FR2005/050996 patent/WO2006059029A2/fr not_active Ceased
- 2005-11-28 PL PL05818937T patent/PL1817065T3/pl unknown
- 2005-11-28 DK DK05818937.4T patent/DK1817065T3/da active
- 2005-11-28 ES ES05818937T patent/ES2364355T3/es not_active Expired - Lifetime
- 2005-11-28 DE DE602005026555T patent/DE602005026555D1/de not_active Expired - Lifetime
- 2005-11-28 JP JP2007542074A patent/JP2008521464A/ja active Pending

Also Published As

Publication number	Publication date
CA2589397C (en)	2015-03-31
ES2364355T3 (es)	2011-08-31
CA2589397A1 (en)	2006-06-08
US20080089918A1 (en)	2008-04-17
DE602005026555D1 (de)	2011-04-07
EP1817065A2 (fr)	2007-08-15
ATE499121T1 (de)	2011-03-15
DK1817065T3 (da)	2011-06-14
WO2006059029A2 (fr)	2006-06-08
FR2878444A1 (fr)	2006-06-02
WO2006059029A3 (fr)	2006-08-31
JP2008521464A (ja)	2008-06-26
FR2878444B1 (fr)	2008-04-25
EP1817065B1 (fr)	2011-02-23

Publication	Publication Date	Title
PL1817065T3 (pl)	2011-09-30	Roztwory wiskoelastyczne zawierające hialuronian sodu i hydroksypropylometylocelulozę
WO2005082414A3 (en)	2006-06-29	Concomitant drugs of a sulfonamide and another therapeutic agent
AP1763A (en)	2007-08-02	Pulmonary administration of chemically modified insulin
CY1105120T1 (el)	2010-03-03	Η αντιμετωπιση αναπνευστικων νοσων
DE60305906D1 (de)	2006-07-20	Okklusionszusammensetzung umfassend ein poly(2-cyanoacrylat)-monomer
PT1401501E (pt)	2005-10-31	Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
TN2010000019A1 (en)	2011-09-26	Solid preparation comprising alogliptin and metformin hydrochloride
GEP20084341B (en)	2008-03-25	Aminoheteroaryl compounds as protein kinase inhibitors
NO20024891L (no)	2002-12-05	Farmasöytiske sammensetninger
EP2260835A3 (en)	2011-09-14	Composition for proteasome inhibition
ZA200305412B (en)	2004-09-02	4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
MX2007002189A (es)	2008-01-11	Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
WO2007139760A3 (en)	2008-10-23	Resorbable polymer compositions for use in medicine, dentistry, and surgery
MY137726A (en)	2009-03-31	Freeze-dried pantoprazole preparation and pantoprazole injection
MXPA03008215A (es)	2004-01-29	Inhibidores de integrina alfa v beta 6.
DK1185253T3 (da)	2004-04-05	Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
DK1715900T3 (da)	2010-05-25	Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
WO2004071374A3 (en)	2004-12-16	Once a day orally administered pharmaceutical compositions
DE502005010427D1 (de)	2010-12-02	Physiologisch aktive zusammensetzung gegen diabetes
WO2008133157A1 (ja)	2008-11-06	体温低下抑制剤
NO20081035L (no)	2008-04-16	Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet
NZ523606A (en)	2004-12-24	Pharmaceutical compositions and methods for use
EA200200853A1 (ru)	2003-02-27	Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
EP1992350A3 (en)	2009-03-11	Medical composition comprising a polysaccharide for elevating the epithelium